GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Park Ha Biological Technology Co BYAH · USD

Consumer Discretionary · US listing · 🇺🇸 United States

Compare

2.18

+0.93%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2024

Revenue

CN¥2.4m

FY2022FY2024

Net income

CN¥478,600

FY2022FY2024

Free cash flow

CN¥874,900

FY2022FY2024

Shareholders' equity

CN¥1.5m

FY2022FY2024

Income statement

Fiscal years

FY2024FY2023FY2022
RevenueCN¥2.4mCN¥2.5mCN¥1.9m
Gross profitCN¥2.2mCN¥2.1mCN¥1.4m
Research and developmentCN¥36,700CN¥30,900CN¥60,700
Operating incomeCN¥793,700CN¥1.2mCN¥197,000
Net incomeCN¥478,600CN¥852,000CN¥191,300
Diluted earnings per share0.020.030.01

Balance sheet

At each fiscal year end

FY2024FY2023FY2022
Total assetsCN¥3.1mCN¥2.3mCN¥2.5m
Cash and short-term investmentsCN¥547,500CN¥1.0mCN¥574,700
Total liabilitiesCN¥1.6mCN¥1.3mCN¥2.4m
Shareholders' equityCN¥1.5mCN¥1.0mCN¥150,300
Shares outstanding25m26m26m

Cash flow

Fiscal years

FY2024FY2023FY2022
Cash from operationsCN¥960,500CN¥126,500CN¥1.4m
Capital spending−CN¥85,600−CN¥22,700−CN¥11,900
Free cash flowCN¥874,900CN¥103,800CN¥1.4m

Latest quarters

By quarter end

Apr 2025Oct 2024Apr 2024Oct 2023
RevenueCN¥1.2mCN¥2.4mCN¥852,900CN¥2.5m
Gross profitCN¥1.2mCN¥2.2mCN¥754,800CN¥2.1m
Operating income−CN¥19.7mCN¥793,700CN¥92,400CN¥1.2m
Net income−CN¥19.8mCN¥478,600CN¥48,900CN¥852,000
Diluted earnings per share-0.740.020.000.03
Total assetsCN¥5.8mCN¥3.1mCN¥2.1m—
Cash and short-term investmentsCN¥1.4mCN¥547,500CN¥932,000—
Shareholders' equityCN¥4.3mCN¥1.5mCN¥1.1m—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin89.5%———

Share price return

Finished calendar years

2025
Return-50%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 8-to-1 reverse split · 6 Aug 2026
  • 50-to-1 reverse split · 20 Feb 2026

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.